SCHEMBL23976223

SCHEMBL23976223

Cc1ccnc(-c2nc3c(c(N(C)CC(=O)NC(C)C)n2)CCC3)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.37
HDAC8 Q9BY41 4/20 0.37
HDAC6 Q9UBN7 4/20 0.37
PDE10A Q9Y233 2/20 0.36
MAPT P10636 3/20 0.36
HTT P42858 2/20 0.36
SPR P35270 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
POLB P06746 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33
FGFR4 P22455 1/20 0.33
FGFR3 P22607 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23976687 0.90 NPC1 (0.37) HDAC1HDAC8HDAC6PDE10AMAPT
SCHEMBL30225169 0.90 NPC1 (0.37) HDAC1HDAC8HDAC6PDE10AMAPT
SCHEMBL23976647 0.88 GAA (0.41) HDAC1HDAC8HDAC6PDE10AMAPT
SCHEMBL23976238 0.87 SPR (0.40) HDAC1HDAC8HDAC6PDE10AMAPT
SCHEMBL30225199 0.87 SPR (0.40) HDAC1HDAC8HDAC6PDE10AMAPT
SCHEMBL23976102 0.87 SPR (0.38) HDAC1HDAC8HDAC6PDE10AMAPT
SCHEMBL23975786 0.86 PDE10A (0.46) HDAC1HDAC8HDAC6PDE10AMAPT
SCHEMBL23975788 0.86 KMT2A (0.45) MEN1ALDH1A1KMT2APOLB
SCHEMBL23975765 0.86 GAA (0.41) HDAC1HDAC8HDAC6PDE10AMAPT
SCHEMBL23976220 0.85 HDAC1 (0.35) HDAC1HDAC8HDAC6PDE10AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222363-A1 CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed